Home > Healthcare > Medical Devices > Therapeutic Devices > Artificial Organs Market
Artificial Organs Market size valued at USD 18 billion in 2019 and is estimated to grow at over 8.9% CAGR from 2020 to 2026. Manufacturers and researchers are continuously focusing on development of artificial organs to improve its chances of acceptance by the receiver. Innovation in artificial organs delivers equally effective treatment solutions to patients that do not qualify for conventional organ transplants. Technological advancements in production process such as bioartificial organ manufacturing, standardization and automation will further stimulate the industry growth.
Report Attribute | Details |
---|---|
Base Year: | 2019 |
Artificial Organs Market Size in 2019: | USD 18.6 Billion |
Forecast Period: | 2020 to 2026 |
Forecast Period 2020 to 2026 CAGR: | 8.9% |
2026 Value Projection: | USD 33.7 Billion |
Historical Data for: | 2015 to 2019 |
No. of Pages: | 101 |
Tables, Charts & Figures: | 146 |
Segments covered: | Organ Type, Material Type |
Growth Drivers: |
|
Pitfalls & Challenges: |
|
Artificial organs reduce probability of organ rejection and provides advantage of mass production. According to the American Transplant Foundation, about 114,000 people are in the waiting list for organ transplantation and approximately 20 people die due to unavailability of organs. With such increasing demand for the organ transplants, the market will witness significant growth as artificial organs help minimize donor organ’s dearth.
Rising cases of organ failure owing to severe sepsis, cardiovascular diseases and trauma incidence drives the number of organ transplant procedures. According to the World Health Organization, about 48.9 million sepsis cases were estimated in 2017. Changing lifestyle and adoption of unhealthy habits such as alcohol consumption and smoking result into liver and heart failure. With growing prevalence of such conditions, the risk of organ dysfunction also increases that will ultimately boost the market demand.
Technological advancements will primarily propel the artificial organs market growth in coming years. The BiVACOR has developed total artificial heart (TAH) device providing innovative option to with end-stage heart failure patients that are unable to qualify for transplants. In addition, SynCardia Systems has introduced temporary implantable total artificial heart device that can perform heart functions for patients with end-stage biventricular heart failure. Thus, launch of advanced innovative products offering beneficial solutions will offer immense opportunities for market expansion.
However, risk associated with organ rejection and significant cost associated with artificial organs can hamper the product demand up to some extent.
Artificial heart market will showcase growth of around 9.7% till 2026. Since last few years, there has been significant increase in total artificial heart implantations. Moreover, advancements including organ development with stem cells and 3D printed hearts will increase its adoption among patients.
According to the Centres for Disease Control and Prevention, about 6.2 million adults suffer through heart failure. Although several non-profit and government organizations are undertaking awareness initiatives regarding organ donation, significantly rising number of heart failures creates organ scarcity resulting into untreated conditions and deaths. Advantage of artificial hearts to increase life-saving treatment accessibility will impact its revenue.
Plastic artificial organs market accounted for more than 22% share in 2019 led by its advantages including biocompatibility and cost-effectivity in manufacturing. With wide adoption of high polymers in artificial organ replacement, the segment will continue to observe growth during the forecast timeline.
Europe artificial organs market held over 25% of revenue share in 2019. During 2019, about 150,000 registrations were reported on organ waiting lists in the region, according to the European registry. Approximately, 41,000 organ transplantations occur every year and 48,000 new registrations are added on the waiting list. Growing burden of heart disease, end-stage kidney and lung disorders will thus continue to provide demand for artificial organs in European countries.
Some of the prominent business participants operating in the artificial organs market include
These leaders are adopting various inorganic growth strategies to gain market share and sustainable competitive advantage.
Click here to Buy Section of this Report
Market, By Organ Type
Market, By Material Type
The above information is provided for the following regions and countries: